BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results

  CEL-SCI Corporation reported financial results for the quarter ended December 31, 2023, as well as key recent clinical and corporate developments.

  February 15, 2024

   · 

  7 min read
• Biotech Bay

  Firefly Bio Debuts With $94 Million Series A Financing

  Firefly Bio emerged from stealth mode with a $94 million Series A financing co-led by founding investor Versant Ventures and by MPM BioImpact alongside Decheng Capital and with participation from Eli Lilly & Company.

  February 15, 2024

   · 

  6 min read
• BioCapital

  Incyte to Present at Upcoming March 2024 Investor Conference

  Incyte announced that it will present at the Cowen 44th Annual Health Care Conference on Monday, March 4, 2024 at 9:50 a.m. in Boston.

  February 15, 2024

   · 

  1 min read
• Lone Star Bio

  EnLiSense CCM Advances Validation of Real-Time IBD Inflammatory Biomarker Monitoring with Two Recent Peer-Reviewed Longitudinal Studies

  EnLiSense CCM, a pioneer in non-invasive sweat-sensor technology for real-time health monitoring, is thrilled to announce a groundbreaking advancement in the world of Inflammatory Bowel Disease management.

  February 15, 2024

   · 

  6 min read
• Business

  G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024

  G1 Therapeutics, Inc., a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate update for the fourth quarter and full year 2023 on Wednesday February 28, 2024, at 8:30 a.m. ET.

  February 15, 2024

   · 

  1 min read
• Genetown

  CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit

  CRISPR Therapeutics announced that members of its senior management team will present at the Citi 2024 Virtual Oncology Leadership Summit on Wednesday, February 21, 2024, at 1:00 p.m. ET.

  February 15, 2024

   · 

  1 min read
• Business

  ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues

  ABVC BioPharma, Inc. announced that it signed a definitive agreement to license certain of its healthcare-related expertise to Senior Paradise, Inc., who will also lease certain of the Company’s properties for further development related to the healthcare industry.

  February 15, 2024

   · 

  4 min read
• Biotech Beach

  Palisade Bio to Present at Digestive Disease Week (DDW) 2024

  Palisade Bio, Inc. announced that its abstract has been accepted for poster presentation at DDW 2024 being held in Washington, D.C., May 18-21, 2024.

  February 15, 2024

   · 

  3 min read
• TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe

  TC BioPharm PLC announced that CEO, Bryan Kobel and Process Development Manager, Dr. Lauren Bor will be featured “Expert Speakers” at the 7th 7th CAR-TCR Summit Europe, February 27-29th in London, UK.

  February 15, 2024

   · 

  1 min read
• Biotech Beach

  Simulations Plus Extends Collaboration with Major Toxicology Research Agency

  Simulations Plus, Inc. announced an extension to the formal agreement with the Translational Toxicology Division at the National Institute of Environmental Health Sciences to support the rapid safety assessment of chemicals in animals and humans.

  February 15, 2024

   · 

  5 min read